Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2020 · 10-Q
Revenue$7.87M$7.87M−3.1% vs Q2 2019 Net Income$953.34K$953.34K+1,676.2% vs Q2 2019 EPS Diluted$0.12$0.12+1,100.0% vs Q2 2019 Operating Income$1,752,186+252.9% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$778,925+363.9% Margins · derivedOperating margin22.3%+16.1 pt vs Q2 2019
Net margin12.1%+11.5 pt vs Q2 2019
ended May 31, 2020 · filed Jul 10, 2020 · 40 d after period end